title: Advances in stroke treatment are within reach.
abstract: Five recent trials have shown that mechanical removal of clot from cerebral arteries after a stroke can achieve a functional independent outcome in up to 60% of patients. This was an absolute benefit of between 13.5% and 31% for patients who had clot removal initiated within 6 hours of symptoms over those who had best medical treatment. Coupled with this, there is a strong drive to develop stroke units internationally and in South Africa. As a starting point, more primary stroke care centres that can administer intravenous thrombolysis are needed. Comprehensive stroke centres that can offer mechanical thrombectomy are available, but more will be required as referral of patients increases. Collaboration of all roleplayers will ensure that we can deliver training and care at the best level for stroke patients.
authors.affiliation: Division of Neurosurgery, Groote Schuur Hospital and Faculty of Health Sciences, University of Cape Town, South Africa. allan.taylor@uct.ac.za.
authors.forename: Allan
authors.initials: A
authors.lastname: Taylor
authors.forename: David
authors.initials: D
authors.lastname: Le Feuvre
authors.forename: Victor
authors.initials: V
authors.lastname: Mngomezulu
authors.forename: Duncan
authors.initials: D
authors.lastname: Royston
authors.forename: Rohen
authors.initials: R
authors.lastname: Harrichandparsard
authors.forename: Coert
authors.initials: C
authors.lastname: De Vries
authors.forename: Arthur
authors.initials: A
authors.lastname: Winter
authors.forename: Francois
authors.initials: F
authors.lastname: Potgieter
mesh_terms: D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D019635:Neurosurgical Procedures / Q000193:education; D018579:Patient Selection; D013019:South Africa; D020521:Stroke / Q000628:therapy*; D017131:Thrombectomy; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator